PRESS RELEASE published on 04/29/2026 at 13:39, 4 months 16 days ago Informations privilégiées / Autres communiqués Medincell annonce une forte croissance des ventes de UZEDY aux Etats-Unis, une formulation injectable approuvée par la FDA pour la schizophrénie et le trouble bipolaire. De nouvelles avancées pour l'olanzapine LAI sont également en cours FDA Schizophrénie Medincell Teva UZEDY
PRESS RELEASE published on 04/29/2026 at 13:39, 4 months 16 days ago Inside Information / Other news releases Medincell's partner Teva Pharmaceuticals reports UZEDY Q1 2026 net sales of $63M, a 62% increase year-on-year. Olanzapine LAI NDA accepted by FDA. Medincell focuses on long-acting injectable treatments across various therapeutic areas Medincell Teva Pharmaceuticals Olanzapine LAI UZEDY Long-acting Injectable
BRIEF published on 04/20/2026 at 11:18, 4 months 25 days ago BNP Paribas Développement crosses a threshold at MEDICELL Euronext Paris Voting Rights BNP Paribas Threshold Crossing MEDICELL
BRIEF published on 04/20/2026 at 11:18, 4 months 25 days ago Franchissement de seuil par BNP Paribas Développement chez MEDINCELL Euronext Paris Droits De Vote Franchissement De Seuil BNP Paribas Medincell
PRESS RELEASE published on 04/20/2026 at 11:13, 4 months 25 days ago Franchissement de seuil Déclaration de franchissement de seuil par BNP Paribas Développement concernant MEDINCELL sur Euronext Paris Euronext Paris Droits De Vote Franchissement De Seuil Medincell BNP Paribas Développement
BRIEF published on 04/02/2026 at 19:05, 5 months 12 days ago Medincell : Mise à jour sur le capital et les droits de vote Droits De Vote Euronext Capital Social Actions AMF
BRIEF published on 04/02/2026 at 19:05, 5 months 12 days ago Medincell: Update on capital and voting rights Share Capital Voting Rights Shares Euronext AMF
PRESS RELEASE published on 04/02/2026 at 19:00, 5 months 12 days ago Informations privilégiées / Autres communiqués Euronext MEDCL divulgue les chiffres du capital social et des droits de vote conformément au règlement de l'AMF. Medincell développe des traitements biopharmaceutiques innovants à action prolongée Droits De Vote Euronext Capital Social Medincell MEDCL
BRIEF published on 02/20/2026 at 21:42, 6 months 22 days ago Teva's Olanzapine Injectable Suspension Gains FDA Nod Schizophrenia Olanzapine Teva Pharmaceuticals FDA Acceptance Long-acting Injectable
BRIEF published on 02/20/2026 at 21:42, 6 months 22 days ago La suspension injectable d'olanzapine de Teva obtient l'approbation de la FDA Schizophrénie Olanzapine Teva Pharmaceuticals Acceptation Par La FDA Injectable À Action Prolongée
Published on 09/15/2026 at 16:35, 8 minutes ago Innodata Appoints Admiral Michael S. Rogers, Former NSA Director and Commander of U.S. Cyber Command, to Its Board of Directors
Published on 09/15/2026 at 15:45, 58 minutes ago Galaxy Ventures Inc. Announces Major Milestones for Qualifying Transaction: TruSilver Completes $2.5 Million Financing and Appoints Former IAMGOLD Chief Geologist Matt Rees as Director and Vice-President of Exploration
Published on 09/15/2026 at 15:35, 1 hour 8 minutes ago Revive Therapeutics to Expand Bucillamine IP and Orphan Drug Portfolio Across Medical Countermeasures and Rare Diseases
Published on 09/15/2026 at 15:25, 1 hour 18 minutes ago Clinical Trial of the Oral Drug NV-387 to Treat Ebola to Start Next Week, Hoping to Reduce Fatalities and Spread, As the Largest Ebola Outbreak is Expanding in DR Congo with 48% Crude Fatality Rate, Says NanoViricides
Published on 09/15/2026 at 15:20, 1 hour 23 minutes ago MicroVision Showcases Expanding Perception Portfolio at IAA Transportation 2026
Published on 09/15/2026 at 16:10, 32 minutes ago Duck Creek Closes Fiscal Year 2026 with Record Bookings as Insurers Accelerate Core Systems Modernization and Agentic AI Adoption
Published on 09/15/2026 at 16:05, 37 minutes ago NOVVA Group secures landmark 3.17 GW renewable energy portfolio from ABO Energy to power global AI infrastructure
Published on 09/15/2026 at 15:22, 1 hour 20 minutes ago Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 09/15/2026 at 07:00, 9 hours 43 minutes ago AXA announces its 2027-2029 strategy and financial targets
Published on 09/15/2026 at 07:00, 9 hours 43 minutes ago AXA annonce son plan stratégique 2027-2029 ainsi que ses objectifs financiers
Published on 09/14/2026 at 18:21, 22 hours 21 minutes ago Reporting on share buyback transactions carried out between September 7 and September 10, 2026
Published on 09/14/2026 at 18:21, 22 hours 21 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 7 et le 10 septembre 2026
Published on 09/14/2026 at 18:00, 22 hours 43 minutes ago Mint franchit une nouvelle étape de sa transformation BtoB : deux signatures majeures viennent conforter une stratégie de croissance récurrente en accélération
